IRIS Accounts Production v24.2.0.383 09961078 director 1.2.23 31.1.24 31.1.24 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh099610782023-01-31099610782024-01-31099610782023-02-012024-01-31099610782022-01-31099610782022-02-012023-01-31099610782023-01-3109961078ns15:EnglandWales2023-02-012024-01-3109961078ns14:PoundSterling2023-02-012024-01-3109961078ns10:Director12023-02-012024-01-3109961078ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3109961078ns10:SmallEntities2023-02-012024-01-3109961078ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3109961078ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3109961078ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3109961078ns10:FullAccounts2023-02-012024-01-3109961078ns10:EntityHasNeverTraded2023-02-012024-01-3109961078ns10:OrdinaryShareClass12023-02-012024-01-3109961078ns10:RegisteredOffice2023-02-012024-01-3109961078ns5:ShareCapital2024-01-3109961078ns5:ShareCapital2023-01-3109961078ns10:OrdinaryShareClass12024-01-3109961078ns5:RetainedEarningsAccumulatedLosses2023-02-012024-01-3109961078ns5:RetainedEarningsAccumulatedLosses2024-01-31
REGISTERED NUMBER: 09961078 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2024

for

Healthmatix Limited

Healthmatix Limited (Registered number: 09961078)






Contents of the Financial Statements
for the Year Ended 31 January 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Healthmatix Limited

Company Information
for the Year Ended 31 January 2024







DIRECTOR: Mr M Papapavlou





REGISTERED OFFICE: 60 Waverley Road
Enfield
Middlesex
EN2 7AQ





REGISTERED NUMBER: 09961078 (England and Wales)





ACCOUNTANTS: CAS MCGEE LTD
Chartered Certified Accountants
130A Darkes Lane
Potters Bar
Hertfordshire
EN6 1AF

Healthmatix Limited (Registered number: 09961078)

Balance Sheet
31 January 2024

31.1.24 31.1.23
Notes £    £   
CURRENT ASSETS
Cash in hand 100 100
TOTAL ASSETS LESS CURRENT
LIABILITIES

100

100

CAPITAL AND RESERVES
Called up share capital 4 100 100
SHAREHOLDERS' FUNDS 100 100

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 2 October 2024 and were signed by:





Mr M Papapavlou - Director


Healthmatix Limited (Registered number: 09961078)

Notes to the Financial Statements
for the Year Ended 31 January 2024

1. STATUTORY INFORMATION

Healthmatix Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

During the financial year and the preceding financial year the company has not traded and has received no income and incurred no expenditure.
Consequently, during those periods the company has made neither a surplus non a deficit.

The company was dormant throughout the current year and previous year.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.24 31.1.23
value: £    £   
100 Ordinary £1.00 100 100

Healthmatix Limited (Registered number: 09961078)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

5. RESERVES
Retained
earnings
£   

Profit for the year -
At 31 January 2024 -

6. GOING CONCERN CONSIDERATION

The Company's management does not see a severe impact of COVID-19 outbreak to its activity. The Company tested the financial impact on the following areas of financial statements that can be affected:
- Breach of trade contracts
- Revenue
- Cost of sales
- Expenditure
- Inventories fair value measurements
- Debt repayment